These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 14584388

  • 1. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T, Kondo R, Miyazaki J, Shiga M, Sugiyama M, Hirose M, Tachikawa S.
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [Abstract] [Full Text] [Related]

  • 2. Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma.
    Horiguchi T, Tachikawa S, Kondo R, Shiga M, Hirose M, Ito T.
    Arzneimittelforschung; 2003 Oct; 53(10):714-21. PubMed ID: 14650364
    [Abstract] [Full Text] [Related]

  • 3. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S, Shimoda T, Kawano T, Mitsuta K, Obase Y, Fukushima C, Matsuse H, Kohno S.
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [Abstract] [Full Text] [Related]

  • 4. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y, Shimoda T, Tomari SY, Mitsuta K, Kawano T, Matsuse H, Kohno S.
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
    Tomita K, Hashimoto K, Matsumoto S, Nakamoto N, Tokuyasu H, Yamasaki A, Yajima H, Sasaki T, Kawasaki Y, Fukutani K.
    Arerugi; 1999 Apr; 48(4):459-65. PubMed ID: 10355150
    [Abstract] [Full Text] [Related]

  • 9. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J, Isono K, Taira M, Tagaya E, Nakata J, Kawatani K, Nagai A.
    Allergy Asthma Proc; 2008 Apr; 29(2):189-96. PubMed ID: 18430318
    [Abstract] [Full Text] [Related]

  • 10. Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
    Barnes NC, Pujet JC.
    Thorax; 1997 Jun; 52(6):523-7. PubMed ID: 9227718
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma.
    Ishioka S, Hozawa S, Haruta Y, Hiyama K, Maeda A, Yamakido M.
    Hiroshima J Med Sci; 1999 Dec; 48(4):105-10. PubMed ID: 10804983
    [Abstract] [Full Text] [Related]

  • 13. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J, Yokohori N, Tagaya E, Kirishi S, Miyamoto Y, Ochiai K, Kondo M, Nagai A.
    Allergy Asthma Proc; 2010 Dec; 31(5):78-84. PubMed ID: 20929598
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S.
    Int J Clin Pharmacol Res; 2003 Dec; 23(2-3):69-74. PubMed ID: 15025036
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast.
    Yanagawa H, Sugita A, Azuma M, Ogawa H, Kitamuro C, Yoneda K, Shinkawa K, Tani K, Sone S.
    Lung; 2004 Dec; 182(1):51-8. PubMed ID: 14752672
    [Abstract] [Full Text] [Related]

  • 18. The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study.
    Obase Y, Shimoda T, Matsuse H, Kondo Y, Machida I, Kawano T, Saeki S, Tomari S, Mitsuta-Izaki K, Matsuo N, Fukushima C, Kohno S.
    Respiration; 2004 Dec; 71(3):225-32. PubMed ID: 15133341
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of response to long-term treatment with Pranlukast in patients with bronchial asthma.
    Niitsuma T, Izawa J, Maruoka N, Nukaga M, Tsuji A, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T.
    J Investig Allergol Clin Immunol; 2004 Dec; 14(4):284-91. PubMed ID: 15736713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.